ホーム>>Signaling Pathways>> GPCR/G protein>> Glucagon Receptor>>PF-06882961

PF-06882961

カタログ番号GC38832

PF-06882961は、グルカゴン様ペプチド-1受容体(GLP-1R)の強力で経口的に利用可能なアゴニストです。

Products are for research use only. Not for human use. We do not sell to patients.

PF-06882961 化学構造

Cas No.: 2230198-02-2

サイズ 価格 在庫数 個数
1mL*10 mM(in DMSO)
$181.00
在庫あり
1mg
$57.00
在庫あり
5mg
$116.00
在庫あり
10mg
$174.00
在庫あり
25mg
$349.00
在庫あり
50mg
$528.00
在庫あり
100mg
$792.00
在庫あり
200mg
$1,188.00
在庫あり
500mg
$1,783.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

PF-06882961 is a potent, orally bioavailable agonist of the glucagon-like peptide-1 receptor (GLP-1R)[1][2].

PF-06882961 (3-240 mg per day) shows mild to moderate damage to the heart, moderate to severe effects on the thymus gland (which helps with managing infection), mild to moderate stomach ulcers at the highest dose level given in the rat[3].PF-06882961 (3-240 mg per day) results one death in an earlier 2-week monkey study at the highest PF-06882961 dose given in that study. No deaths are seen in the 6-week monkey study or any other monkey studies at any of the doses given[3]. Animal Model: 4-week rat[3]

[1]. 20th SCI/RSC Medicinal Chemistry Symposium. [2]. MÉndez M, et al. Design, Synthesis, and Pharmacological Evaluation of Potent Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor (GLP-1R). J Med Chem. 2019 Oct 23. [3]. POSSIBLE SIDE EFFECTS AND RISKS OF THE STUDY DRUG AND PROCEDURES.

レビュー

Review for PF-06882961

Average Rating: 5 ★★★★★ (Based on Reviews and 9 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PF-06882961

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.